This is a company that, knock on wood, they're going to go IPO in the next year or two ... Well, if you think of a Venn diagram of two things, one is reliability or functional safety.
The Austin, Texas-based company and its parent Thoma Bravo sold 60 million shares at $23 apiece, giving SailPoint a valuation ...
Malpani Pipes IPO allotment date today: Malpani Pipes And Fittings IPO share allotment will be finalised today (Monday, February 3).(https://www.malpanipipes.com ...
The primary market to be back in action with nine new initial public offerings (IPO) set to open for subscription next week. Apart from new public issues, the market will also witness six new ...
And Anduril founder Palmer Luckey says this defense technology stock is "on a path to" IPO. Anduril could be the next Palantir -- in more ways than one. Attention, defense investors! In case you ...
In a similar challenge to an IPO in 2023, environmental law group ClientEarth applied for a judicial review after the FCA approved oil producer Ithaca Energy's flotation, but the High Court denied ...
Four IPOs and three SPACs submitted initial filings. Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the range to raise $522 million at a $7.9 billion market cap.
The initial public offering (IPO) of Hexaware Technologies shall open for bidding on Wednesday, February 12. The IT solutions player is offering its shares in the range of Rs 675-708 apiece.
Shein is reportedly poised to chop its valuation by billions of dollars for its anticipated London listing after President Trump ended a trade loophole that allowed the Chinese fast-fashion firm ...
When we introduced the Nasdaq IPO Pulse a year ago, we said it suggested that U.S. “IPO activity… should remain in an uptrend” as we headed into 2024. Then, when we introduced the Nasdaq ...
Apple's board of directors has declared five stock splits since its 1980 initial public offering (IPO). The stock had several 2-for-1 splits between 1987 and 2005 (June 1987, June 2000 ...
The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public.